Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion

Frontiers in Oncology

Volumn 3 JUN, Issue , 2013, Pages

  Risinger, John I ^a   Allard, Jay ^b   Chandran, Uma ^c   Day, Roger ^c   Chandramouli, Gadisetti V R ^d   Miller, Caela ^b   Zahn, Christopher ^e   Oliver, Julie ^f   Litzi, Tracy ^f   Marcus, Charlotte ^b,f   Dubil, Elizabeth ^b,f   Byrd, Kevin ^b,f   Cassablanca, Yovanni ^b,f   Becich, Michael ^c   Berchuck, Andrew ^g   Darcy, Kathleen M ^e   Hamilton, Chad A ^b,e,f   Conrads, Thomas P ^e,f   Maxwell, G Larry ^f,h  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d GenEpria Consulting Inc   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

DLG7; Endometrial cancer; Gene expression; IHH; MELK; RORB; Stage I

Indexed keywords

CALGRANULIN A; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LEUCINE ZIPPER PROTEIN; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PROTIRELIN; RETINOID RELATED ORPHAN RECEPTOR BETA; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; WNT PROTEIN;

ARTICLE; BIOINFORMATICS; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CONTROLLED STUDY; DNA MICROARRAY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; TUMOR INVASION;

EID: 84891589641     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00139     Document Type: Article

References (54)

1. Berchuck, A., and Boyd, J. (1995). Molecular basis of endometrial cancer. Cancer 76, 2034-2040. doi:10.1002/1097-0142(19951115)76:10+<2034::AIDCNCR2820761321>3.0.CO;.
2. Brar, A. K., Kessler, C. A., Meyer, A. J., Cedars, M. I., and Jikihara, H. (1996). Retinoic acid suppresses in-vitro decidualization of human endometrial stromal cells. Mol. Hum. Reprod. 2, 185-193. doi:10.1093/molehr/2.3.185.
3. Cao, Q. J., Belbin, T., Socci, N., Balan, R., Prystowsky, M. B., Childs, G., et al. (2004). Distinctive gene expression profiles by cDNA microarrays in endometrioid and serous carcinomas of the endometrium. Int. J. Gynecol. Pathol. 23, 321-329. doi:10.1097/01.pgp.0000139646.32997.3a.
4. Cheng, Y. H., Utsunomiya, H., Pavone, M. E., Yin, P., and Bulun, S. E. (2011). Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms. J. Mol. Endocrinol. 46, 139-153. doi:10.1530/JME-10-0064.
5. Chiu, A. W., Huang, Y. L., Huan, S. K., Wang, Y. C., Ju, J. P., Chen, M. F., et al. (2002). Potential molecular marker for detecting transitional cell carcinoma. Urology 60, 181-185. doi:10.1016/S0090-4295(02)01672-2.
6. Deligdisch, L., and Holinka, C. F. (1987). Endometrial carcinoma: two diseases? Cancer Detect. Prev. 10, 237-246.
7. Ferguson, S. E., Olshen, A. B., Viale, A., Awtrey, C. S., Barakat, R. R., and Boyd, J. (2004). Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma. Gynecol. Oncol. 92, 719-725. doi:10.1016/j.ygyno.2003.10.038.
8. Ferguson, S. E., Olshen, A. B., Viale, A., Barakat, R. R., and Boyd, J. (2005). Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles. Clin. Cancer Res. 11, 2252-2257. doi:10.1158/1078-0432.CCR-04-1353.
9. Franco, H. L., Lee, K. Y., Broaddus, R. R., White, L. D., Lanske, B., Lydon, J. P., et al. (2010). Ablation of Indian hedgehog in the murine uterus results in decreased cell cycle progression, aberrant epidermal growth factor signaling, and increased estrogen signaling. Biol. Reprod. 82, 783-790. doi:10.1095/biolreprod.109.080259.
10. Fukuchi, T., Sakamoto, M., Tsuda, H., Maruyama, K., Nozawa, S., and Hirohashi, S. (1998). Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res. 58, 3526-3528.
11. Gudmundsson, K. O., Thorsteinsson, L., Sigurjonsson, O. E., Keller, J. R., Olafsson, K., Egeland, T., et al. (2007). Gene expression analysis of hematopoietic progenitor cells identifies Dlg7 as a potential stem cell gene. Stem Cells 25, 1498-1506. doi:10.1634/stemcells.2005-0479.
12. Hayes, M. P., Wang, H., Espinal-Witter, R., Douglas, W., Solomon, G. J., Baker, S. J., et al. (2006). PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia. Clin. Cancer Res. 12, 5932-5935. doi:10.1158/1078-0432.CCR-06-1375.
13. Ignar-Trowbridge, D., Risinger, J. I., Dent, G. A., Kohler, M., Berchuck, A., McLachlan, J. A., et al. (1992). Mutations of the Ki-ras oncogene in endometrial carcinoma. Am. J. Obstet. Gynecol. 167, 227-232. doi:10.1016/S0002-9378(11)91663-9.
14. Kobayashi, K., Sagae, S., Nishioka, Y., Tokino, T., and Kudo, R. (1999). Mutations of the beta-catenin gene in endometrial carcinomas. Jpn. J. Cancer Res. 90, 55-59. doi:10.1111/j.1349-7006.1999.tb00665.x.
15. Kobel, M., Langhammer, T., Huttelmaier, S., Schmitt, W. D., Kriese, K., Dittmer, J., et al. (2006). Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas. Mod. Pathol. 19, 581-587. doi:10.1038/modpathol.3800567.
16. Kohler, M. F., Berkholz, A., Risinger, J. I., Elbendary, A., Boyd, J., and Berchuck, A. (1995). Mutational analysis of the estrogen-receptor gene in endometrial carcinoma. Obstet. Gynecol. 86, 33-37. doi:10.1016/0029-7844(95)00113-6.
17. Kohler, M. F., Carney, P., Dodge, R., Soper, J. T., Clarke-Pearson, D. L., Marks, J. R., et al. (1996). p53 overexpression in advanced-stage endometrial adenocarcinoma. Am. J. Obstet. Gynecol. 175, 1246-1252. doi:10.1016/S0002-9378(96)70036-4.
18. Kuhn, E., Wu, R. C., Guan, B., Wu, G., Zhang, J., Wang, Y., et al. (2012). Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J. Natl. Cancer Inst. 104, 1503-1513. doi:10.1093/jnci/djs345.
19. Kurai, M., Shiozawa, T., Shih, H. C., Miyamoto, T., Feng, Y. Z., Kashima, H., et al. (2005). Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: aurora B as a predictor for poor prognosis in endometrial carcinoma. Hum. Pathol. 36, 1281-1288. doi:10.1016/j.humpath.2005.09.014.
20. Le Gallo, M., O'Hara, A. J., Rudd, M. L., Urick, M. E., Hansen, N. F., O'Neil, N. J., et al. (2012). Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat. Genet. 44, 1310-1315. doi:10.1038/ng.2455.
21. Lee, K., Jeong, J., Kwak, I., Yu, C. T., Lanske, B., Soegiarto, D. W., et al. (2006). Indian hedgehog is a major mediator of progesterone signaling in the mouse uterus. Nat. Genet. 38, 1204-1209. doi:10.1038/ng1874.
22. Li, R., Saito, T., Tanaka, R., Satohisa, S., Adachi, K., Horie, M., et al. (2005). Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium. Cancer Lett. 219, 33-40. doi:10.1016/j.canlet.2004.06.044.
23. Li, X. H., Li, H., Xiao, Z. J., and Piao, Y. S. (2002). Divergent effects of retinoic acids on the expression of ERalpha and 17beta-hydroxysteroid dehydrogenase type 2 in endometrial carcinoma cells (RL 95-2). J. Clin. Endocrinol. Metab. 87, 640-649. doi:10.1210/jc.87.2.640.
24. Liang, H., Cheung, L. W., Li, J., Ju, Z., Yu, S., Stemke-Hale, K., et al. (2012). Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res. 22, 2120-2129. doi:10.1101/gr.137596.112.
25. Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., et al. (2006). Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5, 67. doi:10.1186/1476-4598-5-67.
26. Livasy, C. A., Moore, D., Cance, W. G., and Lininger, R. A. (2004). Focal adhesion kinase overexpression in endometrial neoplasia. Appl. Immunohistochem. Mol. Morphol. 12, 342-345. doi:10.1097/00129039-200412000-00009.
27. Loughney, A. D., Kumarendran, M. K., Thomas, E. J., and Redfern, C. P. (1995). Variation in the expression of cellular retinoid binding proteins in human endometrium throughout the menstrual cycle. Hum. Reprod. 10, 1297-1304.
28. Lukes, A. S., Kohler, M. F., Pieper, C. F., Kerns, B. J., Bentley, R., Rodriguez, G. C., et al. (1994). Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. Cancer 73, 2380-2385. doi:10.1002/1097-0142(19940501)73:9<2380::AIDCNCR2820730922>3.0.CO;2-G.
29. Marie, S. K., Okamoto, O. K., Uno, M., Hasegawa, A. P., Oba-Shinjo, S. M., Cohen, T., et al. (2008). Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int. J. Cancer 122, 807-815. doi:10.1002/ijc.23189.
30. Maxwell, G. L., Chandramouli, G. V., Dainty, L., Litzi, T. J., Berchuck, A., Barrett, J. C., et al. (2005). Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin. Cancer Res. 11, 4056-4066. doi:10.1158/1078-0432.CCR-04-2001.
31. Moreno-Bueno, G., Sanchez-Estevez, C., Cassia, R., Rodriguez-Perales, S., Diaz-Uriarte, R., Dominguez, O., et al. (2003). Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res. 63, 5697-5702.
32. Mutter, G. L., Baak, J. P., Fitzgerald, J. T., Gray, R., Neuberg, D., Kust, G. A., et al. (2001). Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol. Oncol. 83, 177-185. doi:10.1006/gyno.2001.6352.
33. Nakano, I., Masterman-Smith, M., Saigusa, K., Paucar, A. A., Horvath, S., Shoemaker, L., et al. (2008). Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J. Neurosci. Res. 86, 48-60. doi:10.1002/jnr.21471.
34. Oda, K., Stokoe, D., Taketani, Y., and McCormick, F. (2005). High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res. 65, 10669-10673. doi:10.1158/0008-5472.CAN-05-2620.
35. Ohtani, K., Sakamoto, H., Rutherford, T., Chen, Z., Kikuchi, A., Yamamoto, T., et al. (2002). Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett. 179, 79-86. doi:10.1016/S0304-3835(01)00857-6.
36. Ohtani, K., Sakamoto, H., Rutherford, T., Chen, Z., Satoh, K., and Naftolin, F. (1999). Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett. 147, 31-38. doi:10.1016/S0304-3835(99)00272-4.
37. Pickard, M. R., Green, A. R., Ellis, I. O., Caldas, C., Hedge, V. L., Mourtada-Maarabouni, M., et al. (2009). Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer. Breast Cancer Res. 11, R60. doi:10.1186/bcr2350.
38. Pollock, P. M., Gartside, M. G., Dejeza, L. C., Powell, M. A., Mallon, M. A., Davies, H., et al. (2007). Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene 26, 7158-7162. doi:10.1038/sj.onc.1210529.
39. Risinger, J. I., Berchuck, A., Kohler, M. F., Watson, P., Lynch, H. T., and Boyd, J. (1993). Genetic instability of microsatellites in endometrial carcinoma. Cancer Res. 53, 5100-5103.
40. Risinger, J. I., Hayes, A. K., Berchuck, A., and Barrett, J. C. (1997). PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 57, 4736-4738.
41. Risinger, J. I., Maxwell, G. L., Chandramouli, G. V., Jazaeri, A., Aprelikova, O., Patterson, T., et al. (2003). Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res. 63, 6-11.
42. Saidi, S. A., Holland, C. M., Kreil, D. P., Mackay, D. J., Charnock-Jones, D. S., Print, C. G., et al. (2004). Independent component analysis of microarray data in the study of endometrial cancer. Oncogene 23, 6677-6683. doi:10.1038/sj.onc.1207562.
43. Scharer, C. D., Laycock, N., Osunkoya, A. O., Logani, S., McDonald, J. F., Benigno, B. B., et al. (2008). Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells. J. Transl. Med. 6, 79. doi:10.1186/1479-5876-6-79.
44. Siddiqui, N. A., Loughney, A., Thomas, E. J., Dunlop, W., and Redfern, C. P. (1994). Cellular retinoid binding proteins and nuclear retinoic acid receptors in endometrial epithelial cells. Hum. Reprod. 9, 1410-1416.
45. Simon, L., Spiewak, K. A., Ekman, G. C., Kim, J., Lydon, J. P., Bagchi, M. K., et al. (2009). Stromal progesterone receptors mediate induction of Indian Hedgehog (IHH) in uterine epithelium and its downstream targets in uterine stroma. Endocrinology 150, 3871-3876. doi:10.1210/en.2008-1691.
46. Smith, K., Alnifaidy, R., Wei, Q., and Nieman, L. K. (2011). Endometrial Indian hedgehog expression is decreased in women with endometriosis. Fertil. Steril. 95, e2731-e2733.
47. Stehlin-Gaon, C., Willmann, D., Zeyer, D., Sanglier, S., Van Dorsselaer, A., Renaud, J. P., et al. (2003). All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat. Struct. Biol. 10, 820-825. doi:10.1038/nsb979.
48. Talbi, S., Hamilton, A. E., Vo, K. C., Tulac, S., Overgaard, M. T., Dosiou, C., et al. (2006). Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 147, 1097-1121. doi:10.1210/en.2005-1076.
49. Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., et al. (1997). Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57, 3935-3940.
50. Tsou, A. P., Yang, C. W., Huang, C. Y., Yu, R. C., Lee, Y. C., Chang, C. W., et al. (2003). Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma. Oncogene 22, 298-307. doi:10.1038/sj.onc.1206129.
51. Warner, S. L., Stephens, B. J., Nwokenkwo, S., Hostetter, G., Sugeng, A., Hidalgo, M., et al. (2009). Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells. Clin. Cancer Res. 15, 6519-6528. doi:10.1158/1078-0432.CCR-09-0077.
52. Wong, Y. F., Cheung, T. H., Lo, K. W., Yim, S. F., Siu, N. S., Chan, S. C., et al. (2007). Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene 26, 1971-1982. doi:10.1038/sj.onc.1209986.
53. Yu, C. T., Hsu, J. M., Lee, Y. C., Tsou, A. P., Chou, C. K., and Huang, C. Y. (2005). Phosphorylation and stabilization of HURP by Aurora-A: implication of HURP as a transforming target of Aurora-A. Mol. Cell. Biol. 25, 5789-5800. doi:10.1128/MCB.25.14.5789-5800.2005.
54. Zorn, K. K., Bonome, T., Gangi, L., Chandramouli, G. V., Awtrey, C. S., Gardner, G. J., et al. (2005). Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin. Cancer Res. 11, 6422-6430. doi:10.1158/1078-0432.CCR-05-0508.